Miraculins

Developing and Commercializing Diagnostic Tests for Unmet Clinical Needs

  • Skip Navigation
  • About Us
    • The Miraculins Advantage
    • Corporate Profile
    • Our Process
      • Clear Strategies for Growth
      • Exceptional Product
      • Business Model
      • Strong Market
    • Executive Management
    • Scientific Team
    • Board of Directors
    • Message From the President & CEO
    • Corporate Fact Sheet
  • Research & Technology
    • Product Pipeline
    • Cardiovascular Disease
    • Preeclampsia Program
    • Prostate Cancer Program
    • Colorectal Cancer Program
    • Pancreatic Cancer Program
    • Gastric Cancer Program
    • Publications
  • Products & Services
    • PREVU* Skin Cholesterol Test
    • PSP94 Kit
    • Testing Services
  • News
    • Press Releases
    • In the News
  • Investor Relations
    • Stock Information
      • Stock Quote & Chart
      • Transfer Agent
      • Analyst Coverage
    • Financial Filings
      • Financial Statements
      • Annual Reports
    • Investor FAQ
    • Corporate Governance
      • Corporate Governance Policy
      • Audit Committee Charter
      • Insider Trading Policy
      • Whistle Blower Policy
    • Events & Presentations
  • Careers
    • Job Postings
  • Home
  • Contact
  • Sitemap

Investor Relations

  • Print

Financial filings > Financial statements

SEDAR

Financial statements Q4 2010
122 kB PDF

Management's discussion and analysis Q4 2010
1.96 MB PDF

Financial statements Q3 2010
241 kB PDF

Management's discussion and analysis Q3 2010
264 kB PDF

Financial statements Q2 2010
255 kB PDF

Management's discussion and analysis Q2 2010
253 kB PDF

Financial statements Q1 2010
2 MB PDF

Management's discussion and analysis Q1 2010
2 MB PDF

Financial statements Q4 2009
3 MB PDF

Management's discussion and analysis Q4 2009
157 kB PDF

Financial statements Q3 2009
248 kB PDF

Management's discussion and analysis Q3 2009
269 kB PDF

Financial statements Q2 2009
243 kB PDF

Management's discussion and analysis Q2 2009
266 kB PDF

Financial statements Q1 2009
244 kB PDF

Management's discussion and analysis Q1 2009
264 kB PDF

  • Stock Information
    • Stock Quote & Chart
    • Transfer Agent
    • Analyst Coverage
  • Financial Filings
    • Financial Statements
    • Annual Reports
  • Investor FAQ
  • Corporate Governance
    • Corporate Governance Policy
    • Audit Committee Charter
    • Insider Trading Policy
    • Whistle Blower Policy
  • Investor News & Events
    • Events & Presentations
    • News Releases

Sign Up for E-Mail Updates From Miraculins



Sign Up Now Privacy Policy

© 2007 Miraculins Inc. | Legal Information | Privacy Policy